People's Health Press
ISSN 2096-2738 CN 11-9370/R
  • Official WeChat

  • Official Weibo

  • Official headlines

Electronic Journal of Emerging Infectious Diseases ›› 2023, Vol. 8 ›› Issue (2): 58-62.doi: 10.19871/j.cnki.xfcrbzz.2023.02.012

• Original Articles • Previous Articles     Next Articles

A study on the effect of hemodialysis on the blood concentration of rifampicin

Su Chunxiong, Wei Lijuan, Zhou Jia, Huang Aixian, Deng Wenhai, Qin Hongfa, Qin Guoqing, Xu Qiuna, Zou Jun   

  1. Department of Hemodialysis, The Fourth People's Hospital of Nanning, Guangxi AIDS Clinical Treatment Center, Guangxi Nanning 530023, China
  • Received:2022-03-27 Online:2023-04-30 Published:2023-05-19

Abstract: Objective By analyzing the characteristics of rifampicin concentration in hemodialysis patients, to understand whether hemodialysis treatment affects rifampicin concentration, and to provide a basis for the scientific anti-tuberculosis treatment plan for patients receiving long-term hemodialysis. Method Analyzed 149 patients hospitalized with pulmonary tuberculosis in the Fourth People's Hospital of Nanning City from July 2021 to July 2022, and divided the patients into hemodialysis group (43 cases) and non-hemodialysis group (106 cases). By using high performance liquid chromatography analysis to measure the changes of rifampicin blood concentration on post rifampin treatment on days 8 at 2 hours, 4 hours and 6hours. Result There was no statistically significant difference in the blood concentration of rifampicin between hemodialysis group and non-hemodialysis group (P>0.05). Higher rifampicin blood levels accompanied by a sever hepatic dysfunction and exacerbate liver injury after anti-tuberculosis treatmen (P<0.05). The ratio of delayed blood concentration and oral patients is overrepresented in the haemodialysis group. Conclusion There was no significant effect of haemodialysis on the blood concentration of rifampicin, and no top-up dose was needed; the ratio of rifampicin blood level in the haemodialysis group was higher than that in the non-haemodialysis group, which was considered to be affected by the orally. Individualized anti-tuberculosis treatment basing on the blood concentration of rifampicin at 2h, 4h and 6h after the use of drugs can ensure the therapeutic effects.

Key words: Hemodialysis, Rifampicin, Blood drug concentration, Pulmonary tuberculosis

CLC Number: